RecruitingNot ApplicableNCT05953961

90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia

Randomized Study of Therapshere 90-Yittrium Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia


Sponsor

Ochsner Health System

Enrollment

50 participants

Start Date

Aug 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who are candidates for both 90-Yittrium Therasphere transarterial radioembolization (90Y) and microwave ablation (MWA). The study will determine whether treatment with 90Y lowers the risk of disease progression within the first year after diagnosis. Participants will be randomized to receive either first cycle 90Y or MWA and then proceed with standard of care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two treatments for small liver tumors called hepatocellular carcinoma (liver cancer) in patients who also have low albumin levels (a protein in the blood that indicates liver function). The two treatments being compared are microwave ablation (a heat-based procedure to destroy the tumor) and Y-90 radioembolization (delivering targeted radiation through tiny beads inserted into the blood vessels feeding the tumor). **You may be eligible if...** - You have been diagnosed with liver cancer according to standard imaging guidelines - Your tumor is small (3 cm or less), solitary, and cannot be surgically removed - You have low albumin levels (below 3.4 g/dL) - You have not received any prior liver treatment for this cancer - Your liver function and overall health are adequate **You may NOT be eligible if...** - You are pregnant - You have another active cancer at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETherasphere 90Y

Transarterial Radioembolization

DEVICEMicrowave Ablation

Microwave Ablation


Locations(1)

Ochsner Main Campus

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05953961


Related Trials